Fasching PA, Hein A, Kolberg HC, Haberle L, et al. Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer - A single-arm phase II trial (NeoImmunoboost, AGO-B-041). Eur J Cancer 2023;184:1-9.
PMID: 36871424